MAXIMUS (MMS) Given Coverage Optimism Score of 0.12

Media headlines about MAXIMUS (NYSE:MMS) have been trending somewhat positive this week, Accern Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. MAXIMUS earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave media stories about the health services provider an impact score of 45.3390005313746 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

Shares of MAXIMUS (NYSE:MMS) opened at $70.09 on Monday. MAXIMUS has a 12-month low of $51.74 and a 12-month high of $72.71. The stock has a market cap of $4,565.45, a P/E ratio of 22.04, a PEG ratio of 2.63 and a beta of 1.34.

MAXIMUS (NYSE:MMS) last posted its quarterly earnings results on Thursday, November 9th. The health services provider reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.04. MAXIMUS had a net margin of 8.54% and a return on equity of 23.97%. equities analysts anticipate that MAXIMUS will post 3.05 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th will be given a $0.045 dividend. This represents a $0.18 annualized dividend and a dividend yield of 0.26%. The ex-dividend date is Wednesday, February 14th. MAXIMUS’s dividend payout ratio (DPR) is currently 5.66%.

Several analysts have commented on the stock. Zacks Investment Research raised shares of MAXIMUS from a “sell” rating to a “hold” rating in a research report on Wednesday, January 17th. Canaccord Genuity reaffirmed a “buy” rating on shares of MAXIMUS in a research report on Wednesday, December 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $65.60.

In other news, Director Russell A. Beliveau sold 1,500 shares of the business’s stock in a transaction that occurred on Wednesday, November 15th. The shares were sold at an average price of $64.30, for a total value of $96,450.00. Following the sale, the director now owns 40,329 shares of the company’s stock, valued at $2,593,154.70. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, General Counsel David Francis sold 1,373 shares of the business’s stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $65.35, for a total transaction of $89,725.55. Following the completion of the sale, the general counsel now directly owns 13,617 shares in the company, valued at approximately $889,870.95. The disclosure for this sale can be found here. In the last three months, insiders sold 71,417 shares of company stock worth $4,902,785. Insiders own 3.10% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “MAXIMUS (MMS) Given Coverage Optimism Score of 0.12” was first posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://www.truebluetribune.com/2018/01/22/maximus-mms-given-coverage-optimism-score-of-0-12.html.

MAXIMUS Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply